Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Earnings

Take-Two Shares Face Investor Backlash Over Grand Theft Auto VI Delay

Robert Sasse by Robert Sasse
November 17, 2025
in Earnings, Gaming & Metaverse, Tech & Software
0
Take-Two Stock
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

Video game powerhouse Take-Two Interactive delivered a financial rollercoaster for investors this week, presenting stellar quarterly results alongside disappointing news about its most anticipated title. The contrasting developments created significant volatility, with shares experiencing substantial after-hours pressure as the market digested both the strong operational performance and the delayed blockbuster release.

Quarterly Performance Exceeds Expectations

Take-Two’s second quarter fiscal 2026 financial report demonstrated remarkable strength across key metrics:

  • Revenue reached $1.77 billion, representing a substantial 31 percent increase compared to the same period last year
  • Net Bookings achieved a record $1.96 billion, climbing 33 percent year-over-year
  • Reduced Losses showed significant improvement as the net loss narrowed dramatically to $133.9 million from $365.5 million
  • Recurrent Consumer Spending grew by 20 percent, now accounting for 73 percent of total bookings

This robust performance was driven by the company’s established franchises, including NBA 2K, Grand Theft Auto, and Red Dead Redemption, with the mobile gaming division also contributing meaningfully to growth.

Grand Theft Auto VI Release Pushed to Late 2026

Investors received unwelcome news regarding the timeline for Grand Theft Auto VI, the company’s most significant upcoming title. The release date has been moved to November 19, 2026, representing a six-month delay from the originally scheduled May 2026 launch. Company leadership indicated the additional development time will allow for final polishing of the game.

Should investors sell immediately? Or is it worth buying Take-Two?

The market reaction was immediately negative, with Take-Two stock declining sharply in after-hours trading. The disappointment stems from Grand Theft Auto’s status as a revenue powerhouse, where each month of delay translates to significant deferred earnings potential.

Management Raises Guidance Amid Mixed Signals

Despite the high-profile delay, Take-Two’s executive team expressed confidence in the company’s trajectory by raising its full-year outlook. For fiscal year 2026, the company now projects Net Bookings between $6.40 billion and $6.50 billion. This upward revision suggests the underlying business remains healthy even without the immediate contribution from its flagship franchise.

Market analysts maintained a generally positive stance following the announcement. UBS raised its price target on the stock, citing strength in the existing game portfolio. The prevailing expert opinion continues to favor “Moderate Buy” or “Strong Buy” recommendations. Nevertheless, Take-Two shares are navigating turbulent waters as impressive current performance collides with postponed future expectations.

Ad

Take-Two Stock: Buy or Sell?! New Take-Two Analysis from March 25 delivers the answer:

The latest Take-Two figures speak for themselves: Urgent action needed for Take-Two investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Take-Two: Buy or sell? Read more here...

Tags: Take-Two
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

SOXX ETF Stock
Commodities

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock
AI & Quantum Computing

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
Next Post
Cintas Stock

Cintas Shares Face Diverging Analyst Views Amid Market Uncertainty

UPS Stock

UPS Stock: Potential USPS Alliance Could Reshape Delivery Landscape

Nio Stock

Nio's Profitability Target Faces Mounting Headwinds

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com